Light therapy may bring new hope for migraine sufferers

February 8, 2016
Credit: Sasha Wolff/Wikipedia

Migraines often involve heightened sensitivity to light. In a project funded by the Austrian Science Fund FWF, a team of researchers from the Medical University of Vienna is investigating new therapies to treat light sensitivity, which greatly disturbs those affected.

Migraine is a common ailment which debilitates sufferers and can be chronic. About ten percent of adults have recurring migraines, women more often than men, but sufferers also include children and young people. In its "Global Burden of Disease Study", the WHO lists migraine as disabler number six in a list of more than 300 afflictions worldwide.

Migraines are often accompanied by heightened sensitivity to smells, noise or , with light sensitivity representing a particular burden for patients. Light stimuli can also be what triggers headaches. In both cases, those affected are severely diminished in their daily life. Sufferers who cannot bear even normal levels of daylight have to withdraw to darkened rooms during an attack, but are also inclined to avoid light between attacks. Until now, such a deliberate strategy of avoidance has been among the recommendations doctors give to migraine patients.

Improvement instead of avoidance

"With the passage of time we have come to suspect that avoiding light may be detrimental, because it can heighten sensitivity to light – so-called photophobia – even more", explains migraine specialist Christian Wöber. This can be compared to people who are afraid of heights or of confined spaces. Avoiding such fear-provoking situations will not solve the problem. In a recently initiated study funded by the Austrian Science Fund FWF, a team of researchers from the Medical University of Vienna is exploring whether there are other, more sustainable ways of dealing with during . First investigations have shown that the opposite approach, namely desensitising the brain to light stimuli, might be a better strategy than avoiding light. In one-week training sessions patients are exposed to "flickering light" in order to accustom the brain to bright or normal light.

New approaches, contrasting concepts

"The ongoing research project will use functional magnetic resonance imaging (fMRI) to obtain the initial functional brain data that will help to devise the best possible strategy", says the fMRI expert Roland Beisteiner who submitted the project to the FWF. Migraine patients and non-sufferers will be treated with both measures – light exposure and light withdrawal. For the first time, the reactions of their brain will be measured to discern the effects of these two opposite strategies. The project is being conducted by a fMRI research group headed by Beisteiner and a research group on headaches under the leadership of Wöber and Stefan Seidel. The Australian psychologist Paul Martin is assisting the Vienna team. "As yet, we don't know for certain whether desensitisation, i.e. treatment using light, actually improves the brain's tolerance of light. If it does, it would open up a completely new therapeutic avenue", the researchers emphasise. As every patient undergoes both therapies at an interval of three months, the team can compare the effects on individual patients and observe the difference in brain activity between sufferers and healthy control groups.

Progress in migraine research

In recent years, researchers have come to understand many aspects of migraine attacks. Migraine is a genetic disorder and involves functional modifications of the nervous system. Signals from the cortex, the brainstem and the facial nerves trigger an inflammation response in the cerebral membrane leading to typical migraine symptoms. Messenger substances that play an important role in migraines have been identified and have permitted researchers to develop drugs that are specifically effective against migraines. Why an attack is triggered at a certain point or what triggers it are questions that still need further investigation. In the current FWF-project, the researchers from the Medical University of Vienna focus on a fact well known from numerous studies – namely that is linked to a defect in the brain's processing of stimuli. Migraine sufferers often react differently to sensory stimuli such as light, noise and smells compared to non-sufferers. They have a sharper perception of these stimuli and are unable to ward them off. The FWF-project seeks to answer the question as to whether avoiding , the traditionally recommended route, or targeted exposure to light is the better strategy.

Explore further: Migraine triggers may not be as strong as you think

More information: The ongoing study, "Migraine-linked Photophobia," is still looking for patients (age 18 to 40). Send inquiries to stefan.seidel@meduniwien.ac.at

Related Stories

Migraine triggers may not be as strong as you think

January 23, 2013

A new study suggests that triggers for migraine with aura may not be as strong as some people think. The research is published in the January 23, 2013, online issue of Neurology, the medical journal of the American Academy ...

Don't let migraines ruin your holidays

December 26, 2013

(HealthDay)—The holidays can challenge the estimated 30 million migraine sufferers in the United States as they try to deal with crowds, travel delays, stress and other potential headache triggers.

Could your child have migraines?

March 16, 2015

(HealthDay)—Determining if your child has migraine headaches may be difficult because the symptoms aren't always obvious, experts say.

Beware, asthma sufferers: Migraines may worsen

November 30, 2015

Pre-existing asthma may be a strong predictor of future chronic migraine attacks in individuals experiencing occasional migraine headaches, according to researchers from the University of Cincinnati (UC), Montefiore Headache ...

Migraine triggers may all act through a common pathway

December 7, 2015

Migraines can be triggered by a variety of factors, including stress, sleep disruption, noise, odors, and diet. The findings of a new Headache review indicate that many of these factors converge on a common pathway involving ...

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.